Nevro

Nevro company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Through Nevro's pain management solutions, Nevro | HFX and Nevro | SI Joint, Nevro brings together enduring technologies, optimized therapies, and individualized patient support, all built on a foundation of proof that results in a comprehensive solution to relieve the burden of pain for more patients. HFX is a comprehensive solution that includes a Senza Spinal Cord Stimulation system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz. Nevro | SI Joint includes the Nevro1™ SI joint fusion system with integrated transfixing technology provides immediate stabilization with opportunity for long-term fusion and pain relief through a posterior minimally invasive surgical (MIS) approach.

Company Details

Employees
1.14K
Founded
-
Address
1800 Bridge Parkway, Redwood City,california 94065,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Redwood City, California
Looking for a particular Nevro employee's phone or email?

Nevro Questions

News

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewswire

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients GlobeNewswire

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results - PR Newswire

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results PR Newswire

Globus Medical to Acquire Nevro - citybiz

Globus Medical to Acquire Nevro citybiz

Major Medical Device Acquisition: Globus Medical Takes Over Nevro in Strategic $250M Pain Tech Deal - Stock Titan

Major Medical Device Acquisition: Globus Medical Takes Over Nevro in Strategic $250M Pain Tech Deal Stock Titan

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - PR Newswire

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results - PR Newswire

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results PR Newswire

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation - PR Newswire

Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation PR Newswire

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PR Newswire

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally PR Newswire

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches - PR Newswire

New Study Demonstrates Multiple Advantages of Nevro1™, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches PR Newswire

Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain - PR Newswire

Nevro Announces U.S. Full Market Launch of Revolutionary HFX iQ™ Spinal Cord Stimulation System to Personalize Treatment of Chronic Pain PR Newswire

Nevro Announces Acquisition of Vyrsa™ Technologies - PR Newswire

Nevro Announces Acquisition of Vyrsa™ Technologies PR Newswire

Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy - PR Newswire

Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy PR Newswire

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy - PR Newswire

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy PR Newswire

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain - PR Newswire

Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain PR Newswire

New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy - PR Newswire

New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations - PR Newswire

Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations PR Newswire

Nevro Enters Into Cooperation Agreement With Engaged Capital - PR Newswire

Nevro Enters Into Cooperation Agreement With Engaged Capital PR Newswire

Nevro Names New Chief Commercial Officer - PR Newswire

Nevro Names New Chief Commercial Officer PR Newswire

Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN) - PR Newswire

Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN) PR Newswire

Nevro Announces FDA Approval of Costa Rica Manufacturing Operations - PR Newswire

Nevro Announces FDA Approval of Costa Rica Manufacturing Operations PR Newswire

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain - PR Newswire

Nevro Announces FDA Approval of HFX iQ™ Spinal Cord Stimulation System to Personalize the Treatment of Chronic Pain PR Newswire

Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Technologies, Advanced Therapies and End-to-End Patient Support - PR Newswire

Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Technologies, Advanced Therapies and End-to-End Patient Support PR Newswire

Nevro Announces U.S. Launch of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain - PR Newswire

Nevro Announces U.S. Launch of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain PR Newswire

Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain - PR Newswire

Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain PR Newswire

Nevro Announces FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System for Treatment of Non-Surgical Refractory Back Pain (NSRBP) - PR Newswire

Nevro Announces FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System for Treatment of Non-Surgical Refractory Back Pain (NSRBP) PR Newswire

Nevro Announces UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy - PR Newswire

Nevro Announces UnitedHealthcare Coverage for High-Frequency 10 kHz Therapy for the Treatment of Painful Diabetic Neuropathy PR Newswire

Nevro Names Kevin Thornal as New Chief Executive Officer and President - PR Newswire

Nevro Names Kevin Thornal as New Chief Executive Officer and President PR Newswire

FDA Approves Unique SCS System for Chronic Pain - Medical Professionals Reference

FDA Approves Unique SCS System for Chronic Pain Medical Professionals Reference

Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S. - PR Newswire

Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S. PR Newswire

Nevro Receives FDA Approval for Senza II™ Spinal Cord Stimulation System Delivering HF10™ Therapy - PR Newswire

Nevro Receives FDA Approval for Senza II™ Spinal Cord Stimulation System Delivering HF10™ Therapy PR Newswire

Senza SCS System Approval Expanded to Include Nonsurgical Refractory Back Pain - Medical Professionals Reference

Senza SCS System Approval Expanded to Include Nonsurgical Refractory Back Pain Medical Professionals Reference

Nevro’s HFX iQ™ Spinal Cord Technology Receives CE Mark Certification in Europe - TechRound

Nevro’s HFX iQ™ Spinal Cord Technology Receives CE Mark Certification in Europe TechRound

Top Nevro Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant